making it the default reporting framework for the compact’s 5,800 associated company members. It is among the oldest and most widely-adopted methodologies in the world. GRI looks at the economic, ...

There has long been a tension between so-called “reporting burden”, political expediency and providing the transparency that enables efficient markets and sustainable development.

“The proposed transposition into national law of two highly interoperable, complementary standards – the International Sustainability Standards Board (ISSB) standards, focused on investor information ...

No fixed timeline yet” but the regulator will prioritise larger market cap companies and expects them to begin Scope 3 ...

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on ...

GRI Bio, Inc., a biotechnology company focused on developing Natural Killer T cell modulators for inflammatory, fibrotic, and autoimmune diseases, announced that it has regained compliance with ...